Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Eleonora Tulli, Giuseppe Di Cara, Giulia Iapadre, Pasquale Striano & Alberto Verrotti. (2021) An update on brivaracetam for the treatment of pediatric partial epilepsy. Expert Opinion on Pharmacotherapy 22:11, pages 1387-1395.
Read now
Read now
Stefano de Biase, Gian Luigi Gigli & Mariarosaria Valente. (2020) Brivaracetam for the treatment of focal-onset seizures: pharmacokinetic and pharmacodynamic evaluations. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 853-863.
Read now
Read now
Roberta Roberti, Caterina Palleria, Valentina Nesci, Martina Tallarico, Carlo Di Bonaventura, Emanuele Cerulli Irelli, Alessandra Morano, Giovambattista De Sarro, Emilio Russo & Rita Citraro. (2020) Pharmacokinetic considerations about antiseizure medications in the elderly. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 983-995.
Read now
Read now
Alessandra Morano, Luigi Iannone, Caterina Palleria, Martina Fanella, Anna Teresa Giallonardo, Giovambattista De Sarro, Emilio Russo & Carlo Di Bonaventura. (2019) Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy. Expert Opinion on Pharmacotherapy 20:1, pages 25-39.
Read now
Read now
Articles from other publishers (12)
Ting Song, Lingjun Feng, Yulei Xia, Meng Pang, Jianhong Geng, Xiaojun Zhang & Yanqiang Wang. (2023) Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis. Frontiers in Neurology 14.
Crossref
Crossref
Federico M Garofalo, María L Sbaraglini, Emilia M Barrionuevo, Estefanía Peralta, Evelyn L Bonifazi, Alan Talevi & Luciana Gavernet. (2023) Synthesis and biological evaluation of new antiseizure compounds derived from valproic acid. Future Medicinal Chemistry 15:9, pages 735-743.
Crossref
Crossref
Kuan‐Ying Li, Chung‐Yao Hsu & Yuan‐Han Yang. (2023) A review of cognitive and behavioral outcomes of Brivaracetam. The Kaohsiung Journal of Medical Sciences 39:2, pages 104-114.
Crossref
Crossref
Sophie Naddell, Megan Manuel, Rebecca Cavill, Paul White & Katarzyna Sieradzan. (2023) BRIVEST: A ‘real-world’ observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam. Epilepsy & Behavior 138, pages 108985.
Crossref
Crossref
Clifford L. Eastman, Jason S. Fender, Pavel Klein & Raimondo D’Ambrosio. (2021) Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat. Journal of Pharmacology and Experimental Therapeutics 379:3, pages 310-323.
Crossref
Crossref
Mukund Jha, Ozair Alam, Mohd. Javed Naim, Vrinda Sharma, Parth Bhatia, Aadil Ahmad Sheikh, Farah Nawaz, Perwaiz Alam, Ajay Manaithiya, Vivek Kumar, Shagufi Nazar & Nadeem Siddiqui. (2020) Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking. European Journal of Pharmaceutical Sciences 153, pages 105494.
Crossref
Crossref
Sara McGuire, Gustavo Silva, Darshan Lal, Divya S. KhuranaAgustin Legido, Daphne Hasbani, Karen S. Carvalho, Joseph Melvin & Ignacio Valencia. (2019) Safety and Efficacy of Brivaracetam in Pediatric Refractory Epilepsy: A Single-Center Clinical Experience. Journal of Child Neurology 35:2, pages 102-105.
Crossref
Crossref
Joel M Oster. (2019) Brivaracetam: a newly approved medication for epilepsy. Future Neurology 14:3, pages FNL23.
Crossref
Crossref
Solomiya Tsymbalyuk, Madeleine Smith, Charles Gore, Orest Tsymbalyuk, Svetlana Ivanova, Charles Sansur, Volodymyr Gerzanich & J Marc Simard. (2019) Brivaracetam attenuates pain behaviors in a murine model of neuropathic pain. Molecular Pain 15, pages 174480691988650.
Crossref
Crossref
Evangelia Theochari, Hannah Cock, Dora Lozsadi, Clare Galtrey, Jan Arevalo & Marco Mula. (2019) Brivaracetam in adults with drug-resistant epilepsy and psychiatric comorbidities. Epilepsy & Behavior 90, pages 129-131.
Crossref
Crossref
Brian Raymer & Samit K. Bhattacharya. (2018) Lead-like Drugs: A Perspective. Journal of Medicinal Chemistry 61:23, pages 10375-10384.
Crossref
Crossref
Qingting Hu, Fang Zhang, Wenhui Teng, Fangfang Hao, Jing Zhang, Mingxiao Yin & Naidong Wang. (2017) Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis. Journal of Neurology 265:1, pages 1-11.
Crossref
Crossref